Switch to:
Nivalis Therapeutics Inc (NAS:NVLS)
Cash to Debt Ratio
No Debt (As of Dec. 2015)

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Nivalis Therapeutics Inc's cash to debt ratio for the quarter that ended in Dec. 2015 was No Debt.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Nivalis Therapeutics Inc could pay off its debt using the cash in hand for the quarter that ended in Dec. 2015.

NVLS' s Cash to Debt Range Over the Past 10 Years
Min: 0.07   Max: No Debt
Current: No Debt

During the past 4 years, Nivalis Therapeutics Inc's highest Cash to Debt Ratio was No Debt. The lowest was 0.07. And the median was 9999.50.

NVLS's Cash to Debt is ranked higher than
64% of the 931 Companies
in the Global Biotechnology industry.

( Industry Median: 61.14 vs. NVLS: No Debt )

Definition

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Current Portion of Long-Term Debt and Long-Term Debt. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Nivalis Therapeutics Inc's Cash to Debt Ratio for the fiscal year that ended in Dec. 2015 is calculated as:

Nivalis Therapeutics Inc had no debt.

Nivalis Therapeutics Inc's Cash to Debt Ratio for the quarter that ended in Dec. 2015 is calculated as:

Nivalis Therapeutics Inc had no debt.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Related Terms

Current Portion of Long-Term Debt, Long-Term Debt, Cash and Cash Equivalents (For Banks and Insurance Companies), Cash, Cash Equivalents, Marketable Securities, Interest Coverage


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Nivalis Therapeutics Inc Annual Data

Dec12Dec13Dec14Dec15
cash2debt 0.000.000.000.000.000.00N/A0.07No DebtNo Debt

Nivalis Therapeutics Inc Quarterly Data

Dec12Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15
cash2debt N/AN/AN/AN/AN/ANo DebtNo DebtNo DebtNo DebtNo Debt
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK